{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:12:56Z","timestamp":1790658776743,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.clnu.2020.09.052","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:53:15Z","timestamp":1602147195000},"page":"3850-3851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polydatin and its potential protective effect on COVID-19"],"prefix":"10.1016","volume":"39","author":[{"given":"Massimo","family":"Bonucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-6449","authenticated-orcid":false,"given":"Rosa Anna","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2020.09.052_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2020.03.022","article-title":"ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection","author":"Barazzoni","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2020.09.052_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/22221751.2020.1741327","article-title":"Clinical observation and management of COVID-19 patients","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.clnu.2020.09.052_bib3","first-page":"104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19 pharmacol","volume":"157","author":"McKee","year":"2020","journal-title":"Res"},{"key":"10.1016\/j.clnu.2020.09.052_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/1534735418755479","article-title":"Integrated cancer treatment in the course of metastatic pancreatic cancer: complete resolution in 2 cases","volume":"17","author":"Bonucci","year":"2018","journal-title":"Integr Canc Ther"},{"key":"10.1016\/j.clnu.2020.09.052_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","article-title":"Down syndrome: neurobiological alterations and therapeutic targets","volume":"98","author":"Vacca","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.clnu.2020.09.052_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.intimp.2015.10.027","article-title":"Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-\u03baB pathway","volume":"29","author":"Jiang","year":"2015","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.clnu.2020.09.052_bib7","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3109\/13880209.2013.792849","article-title":"Polydatin: a review of pharmacology and pharmacokinetics","volume":"51","author":"Du","year":"2013","journal-title":"Pharm Biol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420305240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420305240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:59:56Z","timestamp":1759366796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561420305240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0261561420305240"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2020.09.052","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polydatin and its potential protective effect on COVID-19","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2020.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}